Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells.
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells. J Immunother Cancer. 2020 04; 8(1).